The Heart -- Incremental new data from the Embolic Protection in Patients with Atrial Fibrillation (PROTECT-AF) study has shown continued efficacy and safety with the device used to close the left atrial appendage (LAA) as a stroke-prevention strategy in patients with nonvalvular atrial fibrillation.
